Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2022
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability-High Locally Advanced Rectal CancerHideaki Bando, Yuichiro Tsukada, Koji Inamori, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 2, 2024
Prognostic and predictive factors for the efficacy and safety of trastuzumab deruxtecan in HER2-positive gastric or gastroesophageal junction cancerAmane Jubashi, Izuma Nakayama, Shigehiro Koganemaru, et al.
JCO Oncology Practice|December 19, 2025
Durable Complete Response and Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer: A Case Series of PatientsShinpei Ushiyama, Takumi Habu, Izuma Nakayama, et al.
Annals of Surgery|March 21, 2025
Circulating Tumor DNA Assessment to Predict Risk of Recurrence after Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational StudyShogo Takei, Daisuke Kotani, George Laliotis, et al.
British Journal of Cancer|August 2, 2023
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)Koji Ando, Yoshiaki Nakamura, Hiroyuki Kitao, et al.
Nature Communications|August 14, 2025
HIBRID: histology-based risk-stratification with deep learning and ctDNA in colorectal cancerChiara M L Loeffler, Hideaki Bando, Srividhya Sainath, et al.
Frontiers in Oncology|March 25, 2021
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)Keigo Chida, Daisuke Kotani, Toshikazu Moriwaki, et al.
Annals of Surgery|September 26, 2025
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort StudyKoji Ando, Atsushi Hamabe, Yoshiaki Nakamura, et al.
JCO Precision Oncology|August 1, 2025
Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological FactorsAmane Jubashi, Izuma Nakayama, Naoya Sakamoto, et al.
JCO Precision Oncology|February 1, 2022
Atypical RAS Mutations in Metastatic Colorectal CancerFilippo Pietrantonio, Rona Yaeger, Alexa B Schrock, et al.
Pageof 9